A new six-figure grant ensures that Georgia Tech students and faculty continue to have access to vital open-source software resources. The Open Source Program Office (OSPO) provides expert advice, ...

Fathom Holdings Inc. (NASDAQ:FTHM) is one of the best long term penny stocks with huge upside potential. On October 16, Fathom Holdings announced the acquisition of START Real Estate, which is a ...

Abstract: Deploying federated learning (FL) in mobile edge computing (MEC) networks has become a prevalent approach to distributed learning. However, the inherent heterogeneity in computing, ...

Sierra Leone Telegraph: 23 October 2025: Open Startup (OST) announces the launch of GROW 3.0, the third cohort of its flagship Investment Readiness Program designed to empower advanced African ...

PAR Technology Corporation (NYSE: PAR), a leading foodservice technology provider, today announced that Krystal Restaurants LLC, the iconic Southern slider chain, has selected PAR Punchh® to power its ...

The ACS Approval Program promotes excellence in chemistry education for undergraduate students through approval of baccalaureate chemistry programs. ACS-approved programs offer a broad-based and ...

What is ACS Program-in-a-Box? Gather to watch a 75-minute interactive livestream broadcast from ACS Headquarters featuring technical presentations from experts, Q&A, "ChemClash" chemistry trivia, ...

Nic Carter says quantum computing is the biggest long-term risk to bitcoin’s core cryptography and urges developers to treat it with urgency, not as science fiction. In an essay published Monday, the ...

Some residents in Burnaby, B.C., are concerned new multiplex homes aren't fitting into existing neighbourhoods. As Johna Baylon reports, city council has agreed the heights and sizes for future ...

AWS re/Start, a full-time, classroom-based skills development and training program, has been preparing individuals for careers in the cloud and connecting them to potential employers since 2017. In ...

Genentech plans to offer its flu medicine at a lower price through its first direct-to-patient program as the Trump administration pushes for more affordable U.S. drug prices. Genentech, a member of ...